Screener
AbCellera Biologics Inc. ABCL Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
| Line item | December 31, 2025 | June 30, 2026 |
|---|---|---|
| Total current liabilities | 64,307 | 53,189 |
| Long-term liabilities: | ||
| Operating lease liability | 137,403 | 129,948 |
| Deferred revenue | 3,500 | 40,450 |
| Deferred government contributions | 174,453 | 178,254 |
| Other long-term liabilities | 10,383 | 9,714 |
| Total long-term liabilities | 325,739 | 358,366 |
| Total liabilities | 390,046 | 411,555 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is AbCellera Biologics Inc.'s contract liabilities, non-current?
- AbCellera Biologics Inc. (ABCL) reported contract liabilities, non-current of $40.45M in Q2 2026.
- How has AbCellera Biologics Inc.'s contract liabilities, non-current changed year-over-year?
- AbCellera Biologics Inc.'s contract liabilities, non-current increased by 247.7% year-over-year, from $11.63M to $40.45M.
- What is the long-term trend for AbCellera Biologics Inc.'s contract liabilities, non-current?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s contract liabilities, non-current has grown at a -40.2% compound annual growth rate (CAGR), from $27.41M to $3.5M.
- What does contract liabilities, non-current mean?
- Obligation to transfer goods or services for which payment has been received, expected to be satisfied beyond one year.
Ask your AI about AbCellera Biologics Inc.'s contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude